Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor

Table 2 Description of the five recurrences

	Age at diagnosis	FIGO staging	Intraoperative/pathologic cyst rupture	Approach	Kind of operation (none of them had any re-resection)	Serum marker at diagnosis	Years from first surgery to recurrence	Nature of relapses	Recurrence site	Treatment for relapse	Last control status	Time of follow-up (years)
1	34.53	IA	No	LSC	Adnexectomy	CA199 = 7939	1.4	IOT mucinous intestinal	contralateral ovary, IA	debulking	Free of disease	6.06
		Neg washings				CA199 = 7939
		Neg washings				CA125 = 4387
2	35.63	IC	No / Yes	LT	Adnexectomy		2	BOT serous	contralateral ovary	USO + TAH	Free of disease	10.14
2	35.63	Neg washings	No / Yes	LT	Adnexectomy		2	BOT serous	contralateral ovary	USO + TAH	Free of disease	10.14
3	20.30	IC	No / Yes	LSC	Cystectomy		2	BOT mucinous intestinal	same ovary	debulking	Free of disease	5.80
3	20.30	Neg washings	No / Yes	LSC	Cystectomy		2	BOT mucinous intestinal	same ovary	debulking	Free of disease	5.80
4	62.62	IC	Yes	LSC	Adnexectomy	CA125 = 554	6.2	IOT serous	pelvic lymph node IIIC	debulking + chemotherapy	Alive with disease	9.66
4	62.62	Neg washings	Yes	LSC	Adnexectomy	CA125 = 554	6.2	IOT serous	pelvic lymph node IIIC	debulking + chemotherapy	Alive with disease	9.66
5	38.42	IA	No	LT	Adnexectomy		4.7	IOT mucinous intestinal	positive ascites, IIC	debulking	Dead of disease	6.69
		Neg washings

BOT, borderline ovarian tumor; IOT, invasive ovarian tumor; LSC, laparoscopy; LT, laparotomy; USO + TAH, unilateral oophorectomy plus total abdominal hysterectomy.

ISSN: 1477-7819